SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001404644-24-000080
Filing Date
2024-06-21
Accepted
2024-06-21 08:32:30
Documents
51
Period of Report
2024-06-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20240621.htm   iXBRL 8-K 26956
2 EX-99.1 june2024ngnecorporatepre.htm EX-99.1 41287
6 june2024ngnecorporatepre001.jpg GRAPHIC 103550
7 june2024ngnecorporatepre002.jpg GRAPHIC 261284
8 june2024ngnecorporatepre003.jpg GRAPHIC 97858
9 june2024ngnecorporatepre004.jpg GRAPHIC 66497
10 june2024ngnecorporatepre005.jpg GRAPHIC 110900
11 june2024ngnecorporatepre006.jpg GRAPHIC 130345
12 june2024ngnecorporatepre007.jpg GRAPHIC 67123
13 june2024ngnecorporatepre008.jpg GRAPHIC 37226
14 june2024ngnecorporatepre009.jpg GRAPHIC 115271
15 june2024ngnecorporatepre010.jpg GRAPHIC 112250
16 june2024ngnecorporatepre011.jpg GRAPHIC 86530
17 june2024ngnecorporatepre012.jpg GRAPHIC 87049
18 june2024ngnecorporatepre013.jpg GRAPHIC 88041
19 june2024ngnecorporatepre014.jpg GRAPHIC 81626
20 june2024ngnecorporatepre015.jpg GRAPHIC 93895
21 june2024ngnecorporatepre016.jpg GRAPHIC 124916
22 june2024ngnecorporatepre017.jpg GRAPHIC 100219
23 june2024ngnecorporatepre018.jpg GRAPHIC 157958
24 june2024ngnecorporatepre019.jpg GRAPHIC 133944
25 june2024ngnecorporatepre020.jpg GRAPHIC 92536
26 june2024ngnecorporatepre021.jpg GRAPHIC 101606
27 june2024ngnecorporatepre022.jpg GRAPHIC 40373
28 june2024ngnecorporatepre023.jpg GRAPHIC 80053
29 june2024ngnecorporatepre024.jpg GRAPHIC 89684
30 june2024ngnecorporatepre025.jpg GRAPHIC 96520
31 june2024ngnecorporatepre026.jpg GRAPHIC 108132
32 june2024ngnecorporatepre027.jpg GRAPHIC 37219
33 june2024ngnecorporatepre028.jpg GRAPHIC 86591
34 june2024ngnecorporatepre029.jpg GRAPHIC 71082
35 june2024ngnecorporatepre030.jpg GRAPHIC 30304
36 june2024ngnecorporatepre031.jpg GRAPHIC 119929
37 june2024ngnecorporatepre032.jpg GRAPHIC 82824
38 june2024ngnecorporatepre033.jpg GRAPHIC 92092
39 june2024ngnecorporatepre034.jpg GRAPHIC 112756
40 june2024ngnecorporatepre035.jpg GRAPHIC 122040
41 june2024ngnecorporatepre036.jpg GRAPHIC 78749
42 june2024ngnecorporatepre037.jpg GRAPHIC 87388
  Complete submission text file 0001404644-24-000080.txt   5155289

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20240621.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20240621_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20240621_pre.xml EX-101.PRE 13050
54 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20240621_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 241058399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)